April 15, 2019
Article
Alexander Drilon, MD, discussed updated findings with larotrectinib in NTRK fusion–positive tumors and entrectinib in ROS1 fusion–positive NSCLC.
November 17, 2018
Article
The investigational agent avapritinib demonstrated encouraging response rates in patients with advanced gastrointestinal stromal tumors and PDGFRα D842V-driven GIST, according to findings presented during the 2018 Annual Meeting of the Connective Tissue Oncology Society in Rome, Italy.
November 15, 2018
Article
Patrick Schöffski, MD, MPH, discussed the key findings from the CREATE trial, the next steps for research into inflammatory myofibroblastic tumor, and the regulatory challenges for approval of drugs for rare cancers.
October 03, 2018
Article
Bruno Sangro, MD, discusses the current landscape for systemic therapies, new directions with immunotherapy, and the need for greater research into combination therapies for HCC.
September 14, 2018
Article
Fabio Piscaglia, MD, discusses the updated 2018 European Association for the Study of the Liver clinical guidelines, which were presented during the 12th International Liver Cancer Association Annual Conference in London, United Kingdom.